SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Account Payables
Amounts the company owes suppliers for goods and services received.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables of $3.51M in Q1 FY2026
Q1 FY2026 account payables was $3.51M.
Context
- Account payables amounted to 1.4% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 2.7M USD
- Year-over-year change
- —
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.7M | — |
Account Payables vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
- Account payables amounts to 1.4% of total assets for SGP, versus a peer median of 2.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $971M USD | +8.6% | +2.5% | 3.1% | |
| Jun 2026 | $426M USD | -5.1% | +7.0% | 3.1% | |
| Jun 2026 | $19.14M USD | +39.9% | +19.6% | 2.1% | |
| Mar 2026 | $18.81M USD | +14.6% | +21.0% | 6.5% | |
| Apr 2026 | $8.7M USD | -24.2% | -0.0% | 1.9% | |
| Mar 2026 | $8.03M USD | +73.5% | -6.8% | 1.1% | |
| Mar 2026 | $7.12M USD | +0.2% | +26.8% | 2.3% | |
| Mar 2026 | CHF 4.48M CHF | +3.0% | -22.5% | 1.8% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $3.51M USD | — | — | 1.4% |
| Mar 2026 | $1.49M USD | -46.3% | -20.6% | 1.4% | |
| Peer median (excluding SGP) | — | +3.0% | +2.5% | 2.1% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.